One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled
HTL will build, validate and operate a botulinum manufacturing facility in the US
A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges
The revenues and profits derived from the new subsidiary will be consolidated in the parent company
_256_384.jpeg)
The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio
The co-investment of CHF 4 million will result in capacity expansion and support the market introduction of the customer's lead compound
Anti-malaria API facility will be operational in 15-18 months
Ibuprofen and Famotidine Tablets is an AB-rated generic therapeutic equivalent version of Horizon Medicines LLC’s Duexis Tablets, 800 mg/26.6 mg
Robust demand for the product across the Middle East, Africa and Latin America
The govt has rolled out three schemes for promoting the manufacture of API
Subscribe To Our Newsletter & Stay Updated
